55 results
8-K
EX-10.1
CRVS
Corvus Pharmaceuticals Inc
6 May 24
Entry into a Material Definitive Agreement
4:11pm
-term indebtedness, long-term indebtedness, net current assets or net assets of the Company and its Subsidiaries.
(g) Litigation. Except as disclosed … : (a) for the redemption of any Common Stock or Common Stock Equivalents, (b) for the settlement of any outstanding litigation or (c) in violation of FCPA or OFAC
8-K
CRVS
Corvus Pharmaceuticals Inc
6 May 24
Entry into a Material Definitive Agreement
4:11pm
of the Private Securities Litigation Reform Act of 1995. The Company intends such forward-looking statements to be covered by the safe harbor provisions
424B5
CRVS
Corvus Pharmaceuticals Inc
3 May 24
Prospectus supplement for primary offering
4:05pm
-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 concerning our business, operations and financial performance … in the Private Securities Litigation Reform Act of 1995.
S-3
PROSPECTUS SUPPLEMENT SUMMARY
This summary provides a general overview of selected information
8-K
EX-1.1
ertr2
2 Nov 21
Entry into a Material Definitive Agreement
6:10am
424B5
uetrw816 am1
2 Nov 21
Prospectus supplement for primary offering
6:05am